FIGURE 1.

Flowchart for management of new onset loss of sense of smell during the COVID‐19 pandemic. INCS, intranasal corticosteroids; OCS, oral corticosteroids. Optional indicates that consensus was achived at the 60% and not the 70% threshold, highlighting ongoing uncertainty regarding the usage